These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2868761)

  • 21. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tardive dyskinesia in bipolar affective disorder: relationship to lithium therapy.
    Dinan TG; Kohen D
    Br J Psychiatry; 1989 Jul; 155():55-7. PubMed ID: 2575003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of clonazepam in an elderly bipolar patient with tardive dyskinesia: a case report.
    Gerding LB; Labbate LA
    Ann Clin Psychiatry; 1999 Jun; 11(2):87-9. PubMed ID: 10440526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluctuation of tardive dyskinesia.
    Caligiuri MP; Lohr JB; Vaughan RM; McAdams LA
    Biol Psychiatry; 1995 Sep; 38(5):336-9. PubMed ID: 7495929
    [No Abstract]   [Full Text] [Related]  

  • 25. Gabapentin in antipsychotic-induced tardive dyskinesia: results of 1-year follow-up.
    Hardoy MC; Carta MG; Carpiniello B; Cianchetti C; Congia S; D'Errico I; Emanuelli G; Garonna F; Hardoy MJ; Nardini M
    J Affect Disord; 2003 Jul; 75(2):125-30. PubMed ID: 12798252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of tardive dyskinesia and mania with RBC lithium determinations.
    Ereshefsky L; Rubin TN; Friedman S
    Am J Psychiatry; 1979 Apr; 136(4B):570-3. PubMed ID: 34329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine and improvement of tardive dyskinesia.
    Kucerová H
    Eur Psychiatry; 2002 Nov; 17(7):421-4. PubMed ID: 12547311
    [No Abstract]   [Full Text] [Related]  

  • 28. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of state-dependent reversal of tardive dyskinesia: phenomenological probe in humans.
    Goswami U; Narayanan HS; Channabasavanna SM
    J Clin Psychopharmacol; 1985 Feb; 5(1):48-50. PubMed ID: 2857733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of persistent myoclonic tardive dystonia with verapamil.
    Abad V; Ovsiew F
    Br J Psychiatry; 1993 Apr; 162():554-6. PubMed ID: 8097657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluperlapine in tardive dyskinesia and parkinsonism.
    Korsgaard S; Noring U; Gerlach J
    Psychopharmacology (Berl); 1984; 84(1):76-9. PubMed ID: 6149595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EMG patterns in abnormal involuntary movements induced by neuroleptics.
    Bathien N; Koutlidis RM; Rondot P
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):1002-8. PubMed ID: 6148381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of abnormal respiratory movements in schizophrenic, bipolar and mentally handicapped patients with typical tardive dyskinesia.
    Youssef HA; Waddington JL
    Int Clin Psychopharmacol; 1989 Jan; 4(1):55-9. PubMed ID: 2574204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report.
    Joe S; Park J; Lim J; Park C; Ahn J
    BMC Psychiatry; 2015 Oct; 15():253. PubMed ID: 26482558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment of tardive dyskinesia with clonidine and neuroleptics: a follow-up study of three cases for three years.
    Nishikawa T; Tanaka M; Koga I; Uchida Y
    Psychopharmacology (Berl); 1983; 80(4):374-5. PubMed ID: 6137858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000207. PubMed ID: 10796324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study.
    Karniol IG; Portela W
    Braz J Med Biol Res; 1982 Dec; 15(6):389-94. PubMed ID: 6135468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1988 May; 145(5):613-6. PubMed ID: 2895985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.